BASEL (dpa-AFX) - Novartis AG (NVS), said on Monday that its arm, Sandoz has acquired Coalesce Product Development Limited, a British medical and drug delivery devices firm, to boost its respiratory and complex generics.
The financial terms of the transaction were not known.
Sandoz CEO, Richard Saynor, said: 'At Sandoz, we have the experience and expertise to succeed in these fields and this acquisition offers us a significant new growth platform, particularly in the US and Europe, reinforcing our commitment to pioneer access for patients.'
With the acquisition, Sandoz focuses on respiratory medicines and related products as a major accelerator for its long-term growth strategy.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2022 AFX News
